Cytek Biosciences Inc

CTKB

Company Profile

  • Business description

    Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

  • Contact

    47215 Lakeview Boulevard
    FremontCA94538
    USA

    T: +1 877 922-9835

    https://www.cytekbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    688

Stocks News & Analysis

stocks

Acquisition a sign of weakness for overvalued ASX share

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.
stocks

ASX opportunities after earnings season

Finding value in an expensive market.
stocks

3 global ‘buy the dip’ candidates with wide moats

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,107.5020.700.23%
CAC 407,825.241.720.02%
DAX 4023,698.155.50-0.02%
Dow JONES (US)45,834.22273.78-0.59%
FTSE 1009,283.2914.29-0.15%
HKSE26,482.7994.630.36%
NASDAQ22,141.1098.030.44%
Nikkei 22544,768.12395.620.89%
NZX 50 Index13,169.5358.37-0.44%
S&P 5006,584.293.18-0.05%
S&P/ASX 2008,839.8018.400.21%
SSE Composite Index3,872.041.450.04%

Market Movers